NCT06018168

Brief Summary

This study aims to evaluate the efficacy of the MINDBODYSKIN Hormonal Acne Supplement and a prescribed skincare routine of 6 products on facial acne and on symptoms of PMS, compared to a skincare routine of 6 products alone. This study will last for 24 weeks. The study will be conducted as a randomized, controlled trial in which participants will be split into two groups. Both will use the skincare routine, but one group will also take the MINDBODYSKIN supplement in combination with the skincare routine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 30, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2024

Completed
Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

6 months

First QC Date

August 24, 2023

Last Update Submit

February 20, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Changes in facial acne. [Baseline to Week 24]

    Participants will provide photos of their face for virtual skin grading by dermatologist.

    24 weeks

  • Changes in blood serum levels of vitamin A. [Baseline to Week 24]

    Participants will undergo blood draws to assess blood serum levels of vitamin A.

    24 weeks

  • Changes in participants perception of facial acne. [Baseline to Week 24]

    Survey-based assessment (0-5 scale) of participants perception of changes to their facial acne.

    24 weeks

Secondary Outcomes (1)

  • Changes in symptoms of premenstrual syndrome (PMS). [Baseline to Week 24]

    24 weeks

Study Arms (2)

Group One: Skincare Routine Only

ACTIVE COMPARATOR

Participants will follow instructions for the skincare routine only. Participants will complete the routine twice daily.

Other: Skincare Routine

Group Two: Skincare Routine + Supplement

ACTIVE COMPARATOR

Participants will follow instructions for the skincare routine AND will take a daily supplement.

Other: Skincare RoutineDietary Supplement: MINDBODYSKIN Supplement

Interventions

Morning: 1\. GENTLECLEAN - Wash with a quarter-sized amount of lukewarm water. Pat skin dry after. 2 CELLRENEW - Shake well, apply 2-3 pumps over the entire face, and massage into the skin 3. YOUARESUNSHINE - Apply generously and evenly as the last step in the skincare routine (before makeup). Night: 1. VITAMINSCRUB - Wet your face with lukewarm water \& apply a quarter-sized amount to wet palms. Lather until foamy. Gently massage the scrub using circular motions for 5-10 seconds. Rinse with lukewarm water and pat dry. 2. CLEARITY - Apply 2-3 pumps and massage into the skin avoiding the eye area. Let sit for 10-15 minutes. Do not wash off. 3. CELLRENEW - Shake well, apply 2-3 pumps over the entire face, and massage into the skin 4. HYDRAGLOW - Apply a dime-size amount of lotion and massage into the face

Group One: Skincare Routine OnlyGroup Two: Skincare Routine + Supplement
MINDBODYSKIN SupplementDIETARY_SUPPLEMENT

Participants will take 3 capsules daily with a meal. The MINDBODYSKIN acne supplement contains Vitamin A (6,100mcg per serving of 3 capsules), Vitamin B12, Vitamin B-5, 5-Hydroxytryptophan (5-HTP), 3,3'-Diindolymethane (DIM), a proprietary liver blend of milk thistle, dandelion extract and L-glutathione, turmeric root extract, a proprietary digestive blend of protease and betaine hydrochloride, and silicon dioxide.

Group Two: Skincare Routine + Supplement

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female 18 years of age or older Have regular acne Have any noticeable PMS symptoms like stress, bloating, mood swings, acne Be generally healthy (i.e. don't live with any uncontrolled chronic disease besides acne).
  • Have a body weight of \>120 lbs.

You may not qualify if:

  • Have any pre-existing conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
  • Be currently using any prescribed medications for their face Anyone with any known severe allergic reactions Women who are pregnant, breastfeeding or attempting to become pregnant Anyone unwilling to follow the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Acne VulgarisPremenstrual Syndrome

Condition Hierarchy (Ancestors)

Acneiform EruptionsSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland DiseasesMenstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study will be conducted as a randomized, controlled trial in which participants will be split into two groups. Both will use the skincare routine, but one group will also take the MINDBODYSKIN supplement in combination with the skincare routine.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2023

First Posted

August 30, 2023

Study Start

June 30, 2023

Primary Completion

December 30, 2023

Study Completion

January 10, 2024

Last Updated

February 22, 2024

Record last verified: 2024-02

Locations